ReviewCureus2026
Ocular Surgery in Patients With Severe Atherosclerotic Disease: Anesthetic Considerations and Vascular Risk Stratification.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ocular surgery in patients with severe atherosclerotic disease represents a growing clinical challenge due to the increasing prevalence of cardiovascular comorbidities in aging populations. Atherosclerosis, characterized by endothelial dysfunction, inflammation, and arterial stiffness, compromises vascular autoregulation and reduces ocular perfusion, thereby increasing susceptibility to ischemic complications during perioperative hemodynamic fluctuations. In this context, patients undergoing ophthalmic procedures, even those considered low risk, such as cataract surgery, may experience significant cardiovascular and cerebrovascular events. A comprehensive preoperative evaluation is essential and should include detailed cardiovascular history, functional capacity assessment, frailty evaluation, and the use of validated risk indices. Targeted investigations such as electrocardiography, echocardiography, and carotid Doppler imaging allow for the identification of high-risk features and guide perioperative planning. The management of antithrombotic therapy requires an individualized approach that balances thrombotic and bleeding risks, particularly in patients receiving dual antiplatelet therapy or anticoagulation. The choice of anesthetic technique plays a critical role in maintaining hemodynamic stability. Techniques with minimal systemic impact, such as topical anesthesia and Sub-Tenon block, are generally preferred, while general anesthesia should be reserved for selected cases. Intraoperatively, maintaining stable mean arterial pressure, avoiding hypotension and hypertension, and ensuring normocapnia are key strategies to preserve cerebral and ocular perfusion. Postoperative care should focus on early detection of myocardial ischemia, arrhythmias, and neurological complications, as well as timely resumption of antithrombotic therapy. Ultimately, a multidisciplinary and individualized approach is essential to optimize perioperative safety and improve outcomes in this high-risk population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.